Effects of a SVT on Agility and Reactive Agility in Adolescent Male Basketball Players

NCT07409155 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-02-13

No results posted yet for this study

Summary

The aim of this pilot study was to investigate the effects of a stroboscopic training intervention on reactive agility and agility speed in basketball players, using identical movement patterns, and to evaluate perceptual-cognitive indices derived from the relationship between agility and reactive agility performance. This study hypothesized that stroboscopic visual training would significantly improve reactive agility and agility performance in adolescent male basketball players.

Conditions

  • Stroboscopic Visual Training

Interventions

OTHER

Neuromuscular exercise training with stroboscopic glassess

The SVT group performed basketball-specific neuromuscular warm-up exercises combined with stroboscopic glasses (Senaptec Strobe, Beaverton, ABD) at a duty cycle of 100 ms clear/150 ms opaque twice per week, whereas the control group completed the identical neuromuscular warm-up exercise protocol under normal visual conditions without visual perturbation. Specifically, stroboscopic eyewear alternates between transparent and opaque phases at adjustable frequencies, thereby restricting the amount and continuity of visual information available to the athlete. This controlled visual disruption is thought to activate neural networks involved in visual and cognitive processing, compelling athletes to perceive, decide, and respond under conditions of reduced or intermittent visual input.

OTHER

Control group

The control group completed the identical neuromuscular warm-up exercise protocol under normal visual conditions without visual perturbation.

Sponsors & Collaborators

  • Hacettepe University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-11-01
Primary Completion
2026-01-10
Completion
2026-01-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07409155 on ClinicalTrials.gov